Dale E. Williams
Analyst · Stifel, Nicolaus
Thanks, Mark. I'll focus my commentary on the fourth quarter and full year 2012 financial results, and our 2013 guidance. I will also review the highlights of our recent financing transactions that support our planned acquisition of Sealy. Let's begin with an overview. In total, fourth quarter net sales were $341.1 million, a decrease of 7% over the same period last year. North American net sales were down 9% and International net sales decreased 4%. Now by channel, North American retail, net sales were $207.8 million, a decrease of 8%. International and retail sales were down 7% to $87.9 million. On a direct basis, our North American direct channel sales decreased by 17% to $17.5 million, while our direct sales internationally increased 64% to $12.3 million. By product, overall mattress sales were down 5% on a unit decline of 2%. North American mattress sales decreased 5% on a 2% increase in units. In the International segment, mattress sales decreased 7% on a unit decrease of 8%. Total pillow net sales decreased by 8% on a 10% decrease in units. North American pillow sales decreased 26% on a unit decrease of 21%. International pillow sales were up 11% on a 5% increase in units. Sales of our other products, which include items that are normally sold along with the mattress, were down 11% in total and down 13% in North America and down 8% internationally. Gross margin for the quarter was 50%, down 200 basis points year-on-year and up 80 basis points sequentially. On a year-over-year basis, fourth quarter gross margin declined primarily due to the following: product mix and higher new product cost, and floor models associated with rolling out the new products. These impacts were partially offset by improved efficiencies in manufacturing and distribution. On a sequential basis, gross margin increased 80 basis points as a result of favorable commodity costs, decreased promotions and discounts and geographic mix. These benefits were partially offset by product mix and increased manufacturing and distribution costs. Advertising spend in the fourth quarter decreased 14% to [ph] $33 million from last year's fourth quarter. As a percentage of sales, advertising spend was 9.8% in the fourth quarter compared with 10.6% in the fourth quarter last year. Despite the slight reduction in advertising, we've continued to see positive trends in our brand awareness and purchase consideration due to a more effective advertising spend. Excluding transaction and integration costs related to the Sealy transaction, and restructuring costs, we maintained G&A expenses relatively comparable to last year's level in the fourth quarter. We increased R&D expense in the fourth quarter by 69% year-over-year by [ph] $4.5 million. Operating income was $51.3 million, or 15% of sales, as compared to $85.8 million, or 23.4% of sales in the fourth quarter of 2011. Operating income in the fourth quarter of 2012 included $7.6 million of transaction and integration costs related to the proposed Sealy acquisition, as well as $1.5 million of restructuring charges. Interest expense was $5.8 million and included approximately $900,000 related to the closing of our recent high-yield bond offering. The tax rate was 48%. The tax rate reflects the provisions for taxes recorded with respect to the anticipated repatriation of foreign earnings which, in total, was $6 million in the fourth quarter. Without this tax impact, the normalized tax rate for the quarter would have been approximately 32.5%. We recorded earnings per share of $0.39 on a GAAP basis for the fourth quarter of 2012. Adjusted earnings per share were $0.60 in the fourth quarter. Now I will summarize the income statement for the full year 2012. Sales were down 1% in total, North American sales down 4% and International sales were up 6%. Operating margins declined to 18% in 2012 from 24% in the prior year. As a reminder, operating income for the full year 2012 included $11.1 million of transaction and integration-related costs and $1.5 million of restructuring charges. GAAP EPS for the full year 2012 was $1.70. Adjusted EPS was $2.61, down 18% as compared to GAAP EPS of $3.18 for the full year 2011. Next, I'll turn to the balance sheet and cash flow for a brief review. Our accounts receivable balance was essentially flat at 34 days. Inventories were up $2 million year-on-year or 2%. Inventory days increased 2 days to 49 versus the prior year. Payables were up 9 days, primarily due to timing. During the quarter, we generated $36 million of operating cash flow and capital expenditures were $12 million. As it relates to our debt position, we were very pleased to have recently announced the closing and signing of several financing transactions necessary to finance the acquisition of Sealy and to pay related fees and expenses. With these, we are now positioned to fund the acquisition. In mid-December, we completed a $375 million offering of 6 7/8 senior notes due in 2020. We also entered into $1.77 billion senior secured credit facilities, comprised of a revolving credit facility of $350 million, a Term A facility of $550 million and a Term B facility of $870 million. Total proceeds from the sale of the senior notes have been placed in escrow pending release upon receipt of regulatory approvals and the satisfaction of other conditions to the completion of the Sealy acquisition. And similarly, the credit facilities are expected to close and fund in connection with acquisition of Sealy. As a result of these financing activities, we felt it was important to note that we will be incurring certain interest expenses. On the senior notes, we have already pre-funded into escrow $20 million of interest expense. We will accrue it as defined under the terms of the notes. We will also be paying ticking and certain other financing-related fees on the $1.77 billion senior secured facilities until the transaction closes. Further, there will be transaction-related costs incurred at closing, as well as deal-related financing and transaction closing fees amortized over several years thereafter. We plan to recognize these transaction-related expense items and adjust for them accordingly in our non-GAAP performance results. As detailed in the press release, our total indebtedness increased to $1.025 billion due to the $375 million bond transaction. Our funded debt of $651 million at the end of the fourth quarter was relatively comparable to the third quarter level. The cash balance increased by $28 million to $179 million, primarily driven by our international operations. Now I'd like to address guidance. The full year 2013 guidance we provided today is stand-alone for Tempur-Pedic. It does not factor in anticipated net sales or earnings from Sealy in 2013. The company plans to issue updated guidance after the closing of the transaction for the combined entity. With that background, we currently expect 2013 net sales to be approximately $1.425 billion, an increase of approximately 2% versus our 2012 total sales. And we currently expect 2013 adjusted EPS to be approximately $2.55. The first quarter is a challenging comparison. We are expecting mid to high-single-digit growth thereafter. It's important to note that our 2013 adjusted EPS guidance does not factor in transaction and integration costs related to the proposed acquisition of Sealy, interest expense costs on the financing transactions just described, or the future tax provisions to be provided in connection with the anticipated repatriation of foreign earnings together with the transaction. We project our gross margin to be slightly down for the full year as compared to the 50.9% recorded in 2012. We believe that any anticipated benefits from our productivity programs and the slight fixed cost leverage, will be offset by product mix and anticipated slight commodity cost increases. We project our operating margin, adjusted to exclude Sealy transaction and integration costs, to be approximately 17.5% to 18%. We'll be accruing for our equity incentive programs at a more normal level in 2013 as compared to 2012, which benefited from an adjustment of $10 million. We anticipate interest expense for the full year to be approximately $20 million under our current debt facilities. We anticipate capital expenditures will be approximately $35 million. We anticipate the full year tax rate, excluding APB 23, to be approximately 32.5%. We are using a share count of 61.5 million shares for the full year. We do not expect to repurchase any shares due to the pending acquisition of Sealy. Let me give you a little context for our guidance. The $1.425 billion sales guidance for the full year is consistent with the methodology that we've used for the past couple of quarters, specifically projecting that current trends will continue. Our fourth quarter sales of $341 million annualized with industry seasonality would be approximately $1.425 billion. We believe that it remains prudent to plan the year this way. That said, our first quarter is the toughest comparison of the year. We're planning for sales to be flat to slightly down as compared to the fourth quarter 2012 sales of $341 million. We expect our adjusted operating margin to be approximately 17% in the first quarter. Through the first 3 weeks of January, we are tracking to these projections. In considering our guidance, it is possible that our actual performance will vary depending on the success of our new initiatives, macroeconomic conditions and competitive activities, or the consequence of other risk factors we've identified in our press release and SEC filings. As noted in our press release, our guidance and these expectations are based on information available at the time of the release and are subject to changing conditions, many of which are outside the company's control. With that, operator, please open the lines for questions.